J Cañueto1,2, J Martín-Vallejo3, E Cardeñoso-Álvarez4, E Fernández-López1,2, J Pérez-Losada2,5, C Román-Curto1,2. 1. Department of Dermatology, Hospital Universitario de Salamanca, Paseo de San Vicente, Salamanca, Spain. 2. Institute of Biomedical Medicine of Salamanca (IBSAL), Hospital Universitario de Salamanca, Paseo de San Vicente, Salamanca, Spain. 3. Department of Statistics, Facultad de Medicina, Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain. 4. Department of Dermatology, Hospital Virgen de la Concha, Avenida de Requejo, Zamora, Spain. 5. Institute of Molecular and Cellular Cancer Biology (IBMCC), Centro de investigación del Cáncer (CIC), Instituto Mixto Universidad de Salamanca/CSIC, Campus Miguel de Unamuno, Salamanca, Spain.
Abstract
BACKGROUND: Cutaneous squamous cell carcinoma (cSCC) represents the most common form of skin cancer after basal cell carcinoma, and can be both locally invasive and metastatic to distant sites. Growth rate (GR) has been poorly evaluated in cSCC, despite clinical evidence suggesting that GR is an important risk factor in cSCC. AIM: To analyse the influence of GR in cSCC prognosis. METHODS: We retrospectively evaluated GR in a series of 90 cSCCs and tried to correlate GR with prognosis in cSCC. RESULTS: We demonstrated that tumours with a GR of > 4 mm/month exhibit a higher risk of nodal progression and a shorter progression time to lymph node metastasis in cSCC than those with GR of < 4 mm/month. As expected, GR correlated with tumour proliferation, as determined by Ki-67 expression. CONCLUSIONS: We consider a GR of 4 mm/month as the cutoff point that distinguishes between rapid- and slow-progressing tumours and, more importantly, to identify a subset of high-risk cSCCs.
BACKGROUND:Cutaneous squamous cell carcinoma (cSCC) represents the most common form of skin cancer after basal cell carcinoma, and can be both locally invasive and metastatic to distant sites. Growth rate (GR) has been poorly evaluated in cSCC, despite clinical evidence suggesting that GR is an important risk factor in cSCC. AIM: To analyse the influence of GR in cSCC prognosis. METHODS: We retrospectively evaluated GR in a series of 90 cSCCs and tried to correlate GR with prognosis in cSCC. RESULTS: We demonstrated that tumours with a GR of > 4 mm/month exhibit a higher risk of nodal progression and a shorter progression time to lymph node metastasis in cSCC than those with GR of < 4 mm/month. As expected, GR correlated with tumour proliferation, as determined by Ki-67 expression. CONCLUSIONS: We consider a GR of 4 mm/month as the cutoff point that distinguishes between rapid- and slow-progressing tumours and, more importantly, to identify a subset of high-risk cSCCs.
Authors: A Tejera-Vaquerizo; J Cañueto; A Toll; J Santos-Juanes; A Jaka; C Ferrandiz; O Sanmartín; S Ribero; D Moreno-Ramírez; F Almazán; M J Fuente; S Podlipnik; E Nagore Journal: Actas Dermosifiliogr Date: 2020-09-20
Authors: Jacob G J Wihlidal; Keng Yeow Tay; S Danielle MacNeil; Anthony C Nichols; Kevin Fung; John H J Yoo; Adrian I Mendez Journal: Laryngoscope Investig Otolaryngol Date: 2022-08-16
Authors: Guilherme Rabinowits; Michael R Migden; Todd E Schlesinger; Robert L Ferris; Morganna Freeman; Valerie Guild; Shlomo Koyfman; Anna C Pavlick; Neil Swanson; Gregory T Wolf; Scott M Dinehart Journal: JID Innov Date: 2021-08-25
Authors: Tobias E Sangers; Marlies Wakkee; Eline C Kramer-Noels; Tamar Nijsten; Marieke W J Louwman; Elisabeth H Jaspars; Loes M Hollestein Journal: Br J Dermatol Date: 2022-05-01 Impact factor: 11.113
Authors: A Tejera-Vaquerizo; J Cañueto; A Toll; J Santos-Juanes; A Jaka; C Ferrandiz-Pulido; O Sanmartín; S Ribero; D Moreno-Ramírez; F Almazán; M J Fuente; S Podlipnik; E Nagore Journal: Actas Dermosifiliogr (Engl Ed) Date: 2020-05-11
Authors: Young-Sool Hah; Hee Young Cho; Sun Young Jo; Young Sook Park; Eun Phil Heo; Tae-Jin Yoon Journal: Oncol Rep Date: 2019-09-16 Impact factor: 3.906